Anishiya Abrol > Hogan Lovells US LLP > Washington DC, United States > Lawyer Profile
Hogan Lovells US LLP Offices

COLUMBIA SQUARE
555 THIRTEENTH STREET, NW
WASHINGTON DC 20004
United States
- Firm Profile
- Go to...
Anishiya Abrol

Work Department
Intellectual Property
Position
Counsel
Career
Anishiya Abrol supports companies in their development and commercialization of cutting-edge medical therapies and tools. She advises on and negotiates a variety of strategic transactions from collaborations to in-licensing and out-licensing to maximize intellectual property assets, and then assists the company in implementing and integrating the new assets.
Anishiya has been seconded to multiple life sciences companies. She knows the issues facing in-house counsel and works closely with members of the firm’s Regulatory and Privacy Practice groups to provide integrated and practical advice.
Anishiya’s practice encompasses the full life sciences life cycle, from the discovery in the lab to dispensing to a patient. She has an undergraduate science degree, and her curious nature draws her towards early stage research and development transactions and activities, including clinical trial agreements, material transfer agreements, contract research organization (CRO) agreements, core lab agreements, sponsored research, grants, and technology transfers, both domestically and internationally. Recognizing though that a therapy’s primary value lies in the hands of patients, she assists commercialization efforts with support on distribution agreements, specialty pharmacy agreements, co-promotion agreements, authorized generic agreements, out-licensing arrangements, and other similar commercial activities.
Languages
English
Memberships
Chair, Wills for Heroes Program, Virginia Bar Association (2008-2013)
Member, American Health Law Association
Member, Virginia Bar Association
Education
J.D., George Mason University School of Law, magna cum laude, 2004
B.A. Biology, University of Virginia, 1997
B.A. History, University of Virginia, 1997
Lawyer Rankings
United States > Industry focus > Healthcare: life sciences
(Next Generation Partners)Hogan Lovells US LLP ‘s national life sciences practice has a strong reputation for M&A, financing transactions and large-scale commercial deals. It also stands out for its dedicated regulatory offering and its experience in IP litigation and pharmaceutical and medical device product liability proceedings. Its Washington DC-based regulatory team was recently strengthened by the arrival of Jonathan Wasserman, former associate general counsel at Bristol Myers Squibb. It is also highly commended for its Washington DC based FDA and healthcare regulatory team. Contacts in this space include Philip Katz, who leads the group’s pharmaceutical work; Randy Prebula, head of medical devices; Jonathan Kahan and David Fox, who focus on FDA matters; and Anishiya Abrol, a contact for commercial and licensing transactions. The service group is jointly led by Steve Abrams and Lynn Mehler in Philadelphia and Washington DC, respectively. Asher Rubin and Adriana Tibbitts joined Sidley Austin LLP in January 2021; Suzanne Filippi left for Morgan, Lewis & Bockius LLP in April, and Adam Golden left for Freshfields Bruckhaus Deringer LLP in May.
Lawyer Rankings
- Next Generation Partners - United States > Industry focus > Healthcare: life sciences
- Healthcare: life sciences - United States > Industry focus
Top Tier Firm Rankings
- Antitrust > Cartel
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > International trade
- M&A/corporate and commercial > M&A: middle-market (sub-$500m)
- Employment >
- Employment >
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Industry focus > Transport: aviation and air travel - litigation and regulation
- Industry focus > Transport: rail and road - litigation and regulation
Firm Rankings
- Industry focus > Education
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Industry focus > Environment: litigation
- Media, technology and telecoms > Fintech
- Government > Government contracts
- Government > Government relations
- Industry focus > Healthcare: health insurers
- Industry focus > Healthcare: life sciences
- Industry focus > Healthcare: service providers
- Dispute resolution > International litigation
- Media, technology and telecoms > Technology transactions
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Industry focus > Energy litigation: oil and gas
- Industry focus > Energy regulation: conventional power
- Industry focus > Energy regulation: oil and gas
- Industry focus > Energy: renewable/alternative power
- Industry focus > Environment: regulatory
- Labor and employment > Immigration
- Industry focus > Insurance: advice to insurers
- Tax > International tax
- Antitrust > Merger control
- Media, technology and telecoms > Outsourcing
- M&A/corporate and commercial > Shareholder activism
- Finance > Structured finance: derivatives and structured products
- Tax > US taxes: non-contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Capital markets: global offerings
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Restructuring (including bankruptcy): corporate
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Project finance